Non-genomic effects of sex hormones on CLC-1 may contribute to gender differences in myotonia congenita

Neuromuscular Disorders

Volumn 18, Issue 11, 2008, Pages 869-872

  Fialho, Doreen ^a   Kullmann, Dimitri M ^a   Hanna, Michael G ^a   Schorge, Stephanie ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Chloride channel; CLC 1; Hormone; Myotonia congenita; Non genomic

Indexed keywords

PROGESTERONE; TESTOSTERONE;

ARTICLE; CHLORIDE CHANNEL 1 GENE; DISEASE SEVERITY; GENE; GENE MUTATION; HORMONAL REGULATION; NONHUMAN; OOCYTE; PREGNANCY; PRIORITY JOURNAL; SEX DIFFERENCE; SEX TRANSFORMATION; THOMSEN DISEASE; WILD TYPE; XENOPUS;

ANIMALS; CELLS, CULTURED; CHLORIDE CHANNELS; ELECTRODES; ELECTROPHYSIOLOGY; FEMALE; MEMBRANE POTENTIALS; MUTAGENESIS, SITE-DIRECTED; MUTATION; MYOTONIA CONGENITA; OOCYTES; PATCH-CLAMP TECHNIQUES; PROGESTERONE; SEX FACTORS; TESTOSTERONE; XENOPUS;

EID: 53049099136     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2008.07.004     Document Type: Article

References (23)

1. Koch M.C., Steinmeyer K., Lorenz C., Ricker K., Wolf F., Otto M., et al. The skeletal muscle chloride channel in dominant and recessive human myotonia. Science 257 5071 (1992) 797-800
2. Colding-Jorgensen E. Phenotypic variability in myotonia congenita. Muscle Nerve 32 1 (2005) 19-34
3. Wagner S., Deymeer F., Kurz L.L., Benz S., Schleithoff L., Lehmann-Horn F., et al. The dominant chloride channel mutant G200R causing fluctuating myotonia: clinical findings, electrophysiology, and channel pathology. Muscle Nerve 21 9 (1998) 1122-1128
4. Becker P. Myotonia congenita and syndromes associated with myotonia. Georg Thieme Verlag: 1977.
5. Deymeer F., Lehmann-Horn F., Serdaroglu P., Cakirkaya S., Benz S., Rudel R., et al. Electrical myotonia in heterozygous carriers of recessive myotonia congenita. Muscle Nerve 22 1 (1999) 123-125
6. Mailander V., Heine R., Deymeer F., and Lehmann-Horn F. Novel muscle chloride channel mutations and their effects on heterozygous carriers. Am J Hum Genet 58 2 (1996) 317-324
7. Edwards D.P. Regulation of signal transduction pathways by estrogen and progesterone. Annu Rev Physiol 67 (2005) 335-376
8. Gupta S., Mehrotra S., Villalon C.M., Perusquia M., Saxena P.R., and MaassenVanDenBrink A. Potential role of female sex hormones in the pathophysiology of migraine. Pharmacol Ther 113 2 (2007) 321-340
9. Wunderlich F., Benten W.P., Lieberherr M., Guo Z., Stamm O., Wrehlke C., et al. Testosterone signaling in T cells and macrophages. Steroids 67 6 (2002) 535-538
10. Fialho D., Schorge S., Pucovska U., Davies N.P., Labrum R., Haworth A., et al. Chloride channel myotonia: exon 8 hot-spot for dominant-negative interactions. Brain 130 Pt 12 (2007) 3265-3274
11. Federman A.D., Conklin B.R., Schrader K.A., Reed R.R., and Bourne H.R. Hormonal stimulation of adenylyl cyclase through Gi-protein beta gamma subunits. Nature 356 6365 (1992) 159-161
12. Hammes S.R., and Levin E.R. Extranuclear steroid receptors: nature and actions. Endocr Rev 28 7 (2007) 726-741
13. Soldin O.P., Guo T., Weiderpass E., Tractenberg R.E., Hilakivi-Clarke L., and Soldin S.J. Steroid hormone levels in pregnancy and 1 year postpartum using isotope dilution tandem mass spectrometry. Fertil Steril 84 3 (2005) 701-710
14. Madeja M., Musshoff U., and Speckmann E.J. Follicular tissues reduce drug effects on ion channels in oocytes of Xenopus laevis. Eur J Neurosci 9 3 (1997) 599-604
15. Falkenstein E., Tillmann H.C., Christ M., Feuring M., and Wehling M. Multiple actions of steroid hormones - a focus on rapid, nongenomic effects. Pharmacol Rev 52 4 (2000) 513-556
16. Furukawa T., and Kurokawa J. Regulation of cardiac ion channels via non-genomic action of sex steroid hormones: implication for the gender difference in cardiac arrhythmias. Pharmacol Ther 115 1 (2007) 106-115
17. Mesiano S. Myometrial progesterone responsiveness. Semin Reprod Med 25 1 (2007) 5-13
18. Gras F., Brunmair B., Quarre L., Szocs Z., Waldhausl W., and Furnsinn C. Progesterone impairs cell respiration and suppresses a compensatory increase in glucose transport in isolated rat skeletal muscle: a non-genomic mechanism contributing to metabolic adaptation to late pregnancy?. Diabetologia 50 12 (2007) 2544-2552
19. Norman A.W., Nemere I., Zhou L.X., Bishop J.E., Lowe K.E., Maiyar A.C., et al. 1,25(OH)2-vitamin D3, a steroid hormone that produces biologic effects via both genomic and nongenomic pathways. J Steroid Biochem Mol Biol 41 3-8 (1992) 231-240
20. Zanello L.P., and Norman A.W. Rapid modulation of osteoblast ion channel responses by 1alpha,25(OH)2-vitamin D3 requires the presence of a functional vitamin D nuclear receptor. Proc Natl Acad Sci USA 101 6 (2004) 1589-1594
21. Uezono Y., Kaibara M., Murasaki O., and Taniyama K. Involvement of G protein betagamma-subunits in diverse signaling induced by G(i/o)-coupled receptors: study using the Xenopus oocyte expression system. Am J Physiol Cell Physiol 287 4 (2004) C885-C894
22. Maguire J.L., Stell B.M., Rafizadeh M., and Mody I. Ovarian cycle-linked changes in GABA(A) receptors mediating tonic inhibition alter seizure susceptibility and anxiety. Nat Neurosci 8 6 (2005) 797-804
23. Rogawski M.A. Progesterone, neurosteroids, and the hormonal basis of catamenial epilepsy. Ann Neurol 53 3 (2003) 288-291